Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence
Authors:
- 23 January 2020
- journal article
- review article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 37 (2) , 225-239
Abstract
Cancer is the leading cause of death in North America. Despite modern advances in cancer therapy, many patients will ultimately develop cancer metastasis resulting in mortality. Surgery to resect early stage solid malignancies remains the cornerstone of cancer treatment. However, surgery places patients at risk of developing post-operative infectious complications that are linked to earlier cancer metastatic recurrence and cancer mortality. Toll-like receptors (TLRs) are evolutionarily-conserved sentinel receptors of the innate immune system that are activated by microbial products present during infection, leading to activation of innate immunity. Numerous types of solid cancer cells also express TLRs, with their activation augmenting their ability to metastasize. Similarly, healthy host-tissue TLRs activated during infection induce a prometastatic environment in the host. Cancer cells additionally secrete TLR activating ligands that activate both cancer TLRs and host TLRs to promote metastasis. Consequently, TLRs are an attractive therapeutic candidate to target infection-induced cancer metastasis and progression.Keywords
This publication has 183 references indexed in Scilit:
- TLR8: the forgotten relative revindicatedCellular & Molecular Immunology, 2012
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and ImmunityImmunity, 2011
- Toll-like receptor 2 is present in the microenvironment of oral squamous cell carcinomaBritish Journal of Cancer, 2010
- Lymphangiogenesis and lymphatic metastasis in breast cancerPathophysiology, 2010
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasisNature, 2009
- Toll-Like Receptor 5 Engagement Modulates Tumor Development and Growth in a Mouse Xenograft Model of Human Colon CancerGastroenterology, 2008
- Postoperative wound complications and systemic recurrence in breast cancerBritish Journal of Cancer, 2007
- The dsRNA binding site of human Toll-like receptor 3Proceedings of the National Academy of Sciences, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004